Skip to main navigation

News & Events Publications Patient Resources Contact
  • About Us
    • Leadership
    • Board
    • Scientific Advisors
    • Careers & Culture
    • Open Opportunities
  • Science
    • HBV Assets
      • Imdusiran (AB-729)
      • AB-101
  • Pipeline
  • Partnering
  • >
  • Investors
    • Investor Center
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Investor FAQ
    • Contact Us
  • Culture & Careers

Investor Relations

  • Investor Center
  • Stock Information
  • Financial Information
  • Corporate Governance
  • Press Releases
  • Events & Presentations
  • Investor FAQ
  • Contact Us

SEC Filing Details

Document Details

Form
8-K
Filing Date
Mar 15, 2019
Document Date
Mar 13, 2019
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Arbutus Biopharma Corporation
Issuer
ARBUTUS BIOPHARMA CORP

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

  • Email Alerts Email Alerts
  • RSS News Feeds RSS News Feeds
  • Download Library Download Library

© 2026 Arbutus Biopharma

Legal Terms